Neuroendocrine Carcinoma Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
4594 | Date :
Jan, 2023 | Pages :
186 | Region : Global |
Publisher : 99 Strategy
Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the rest of the body.
The somatostatin analogs segment by treatment type is expected to witness high traction in the coming years.
The Global Neuroendocrine Carcinoma Market was valued at xxx million USD with a CAGR xx% from 2018-2022. Subsequently, it will touch xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Neuroendocrine Carcinoma Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Pfizer
Novartis
Chiasma
Ipsen
Abbvie
Valeant
Jubilant
Teva
F.Hoffmann-La Roche
Advanced Accelerator
Mateon
Lexicon
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Chemotherapy
Somatostatin Analogs
Targeted Therapy
In Market segmentation by applications :
Hospital
Clinics
Oncology Centres
Ambulatory Surgery Centres
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Neuroendocrine Carcinoma Market for the forecast period 2023-2030?
• What are the driving forces in the Neuroendocrine Carcinoma Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Neuroendocrine Carcinoma industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Neuroendocrine Carcinoma Market Size Growth Rate by Type (2020-2030)
1.3.2 Chemotherapy
1.3.3 Somatostatin Analogs
1.3.4 Targeted Therapy
1.4 Market Segment by Application
1.4.1 Global Neuroendocrine Carcinoma Market Share by Application (2020-2030)
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Oncology Centres
1.4.5 Ambulatory Surgery Centres
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroendocrine Carcinoma Market Size
2.1.1 Global Neuroendocrine Carcinoma Revenue 2015-2030
2.1.2 Global Neuroendocrine Carcinoma Sales 2015-2030
2.2 Neuroendocrine Carcinoma Growth Rate by Regions
2.2.1 Global Neuroendocrine Carcinoma Sales by Regions 2018 - 2022
2.2.2 Global Neuroendocrine Carcinoma Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Neuroendocrine Carcinoma Sales by Manufacturers
3.1.1 Neuroendocrine Carcinoma Sales by Manufacturers 2018 - 2022
3.1.2 Neuroendocrine Carcinoma Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Neuroendocrine Carcinoma Revenue by Manufacturers (2018 - 2022)
3.2.2 Neuroendocrine Carcinoma Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Neuroendocrine Carcinoma Market Concentration Ratio (CR5 and HHI)
3.3 Neuroendocrine Carcinoma Price by Manufacturers
3.4 Key Manufacturers Neuroendocrine Carcinoma Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Neuroendocrine Carcinoma Market
3.6 Key Manufacturers Neuroendocrine Carcinoma Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Chemotherapy Sales and Revenue (2018 - 2022)
4.1.2 Somatostatin Analogs Sales and Revenue (2018 - 2022)
4.1.3 Targeted Therapy Sales and Revenue (2018 - 2022)
4.2 Global Neuroendocrine Carcinoma Sales Market Share by Type
4.3 Global Neuroendocrine Carcinoma Revenue Market Share by Type
4.4 Neuroendocrine Carcinoma Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Neuroendocrine Carcinoma Sales by Application
6 United States
6.1 United States Neuroendocrine Carcinoma Breakdown Data by Company
6.2 United States Neuroendocrine Carcinoma Breakdown Data by Type
6.3 United States Neuroendocrine Carcinoma Breakdown Data by Application
7 European Union
7.1 European Union Neuroendocrine Carcinoma Breakdown Data by Company
7.2 European Union Neuroendocrine Carcinoma Breakdown Data by Type
7.3 European Union Neuroendocrine Carcinoma Breakdown Data by Application
8 China
8.1 China Neuroendocrine Carcinoma Breakdown Data by Company
8.2 China Neuroendocrine Carcinoma Breakdown Data by Type
8.3 China Neuroendocrine Carcinoma Breakdown Data by Application
9 Rest of World
9.1 Rest of World Neuroendocrine Carcinoma Breakdown Data by Company
9.2 Rest of World Neuroendocrine Carcinoma Breakdown Data by Type
9.3 Rest of World Neuroendocrine Carcinoma Breakdown Data by Application
9.4 Rest of World Neuroendocrine Carcinoma Breakdown Data by Countries
9.4.1 Rest of World Neuroendocrine Carcinoma Sales by Countries
9.4.2 Rest of World Neuroendocrine Carcinoma Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.1.4 Neuroendocrine Carcinoma Product Introduction
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.2.4 Neuroendocrine Carcinoma Product Introduction
10.2.5 Novartis Recent Development
10.3 Chiasma
10.3.1 Chiasma Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.3.4 Neuroendocrine Carcinoma Product Introduction
10.3.5 Chiasma Recent Development
10.4 Ipsen
10.4.1 Ipsen Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.4.4 Neuroendocrine Carcinoma Product Introduction
10.4.5 Ipsen Recent Development
10.5 Abbvie
10.5.1 Abbvie Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.5.4 Neuroendocrine Carcinoma Product Introduction
10.5.5 Abbvie Recent Development
10.6 Valeant
10.6.1 Valeant Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.6.4 Neuroendocrine Carcinoma Product Introduction
10.6.5 Valeant Recent Development
10.7 Jubilant
10.7.1 Jubilant Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.7.4 Neuroendocrine Carcinoma Product Introduction
10.7.5 Jubilant Recent Development
10.8 Teva
10.8.1 Teva Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.8.4 Neuroendocrine Carcinoma Product Introduction
10.8.5 Teva Recent Development
10.9 F.Hoffmann-La Roche
10.9.1 F.Hoffmann-La Roche Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.9.4 Neuroendocrine Carcinoma Product Introduction
10.9.5 F.Hoffmann-La Roche Recent Development
10.10 Advanced Accelerator
10.10.1 Advanced Accelerator Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Neuroendocrine Carcinoma
10.10.4 Neuroendocrine Carcinoma Product Introduction
10.10.5 Advanced Accelerator Recent Development
10.11 Mateon
10.12 Lexicon
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Neuroendocrine Carcinoma Sales Channels
11.2.2 Neuroendocrine Carcinoma Distributors
11.3 Neuroendocrine Carcinoma Customers
12 Market Forecast
12.1 Global Neuroendocrine Carcinoma Sales and Revenue Forecast 2020-2030
12.2 Global Neuroendocrine Carcinoma Sales Forecast by Type
12.3 Global Neuroendocrine Carcinoma Sales Forecast by Application
12.4 Neuroendocrine Carcinoma Forecast by Regions
12.4.1 Global Neuroendocrine Carcinoma Sales Forecast by Regions 2020-2030
12.4.2 Global Neuroendocrine Carcinoma Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.